Terms ending in 2031
Every in-force patent on Optinose Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,038,630 | Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 10,252,010 | Nasal Delivery Devices In force · Medium confidence | OptiNose Inc. | In force | Medium confidence | |
| US 12,083,270 | Delivery Device and Method In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 8,910,629 | Delivery of Gases to the Nasal Airway In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 9,010,325 | Nasal Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 11,291,626 | Nasal Delivery of Oxytocin In force · High confidence | OptiNose Inc. | In force | High confidence | |
| US 9,067,034 | Nasal Delivery Devices In force · High confidence | OptiNose Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.